chrisvoncsefalvay/vaers-outcomes huggingface dataset:
nose started tingling; funny taste in her mouth; It almost felt like she was sneezing; felt like a wush going through system and around neck when give the vaccine; This is a spontaneous report received from a contactable consumer (patient). A female patient received the first dose of bnt162b2 (Pfizer-Biontech COVID-19 vaccine) via unspecified route of administration on 20Apr2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient stated that she felt like a wush going through system and around neck when give the vaccine. Her nose started tingling and she felt a funny taste in her mouth. It almost felt like she was sneezing. The patient asked if this considered an allergic reaction. The outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
hiccup; This case was reported by a pharmacist via call center representative and described the occurrence of hiccups in a 76-year-old male patient who received Herpes zoster (Shingrix) (batch number 73XT7, expiry date 18th June 2024) for prophylaxis.   On 7th February 2023, the patient received the 1st dose of Shingrix. In February 2023, unknown after receiving Shingrix, the patient experienced hiccups. On an unknown date, the outcome of the hiccups was unknown.   It was unknown if the reporter considered the hiccups to be related to Shingrix.     Additional Information: GSK Receipt Date: 08-Feb-2023: The pharmacist called the patient to saw if hiccup after Shingrix first dose was normal or expected.  The patient received Shingrix first dose and started with hiccup.  The reported consented to follow up.
Patient called and said every time she moves her arm it hurts. When at rest no issues. She said it started after her vaccine in August.
At 7:00 pm on 3/29/21, 30 hrs after vaccine I started to get a severe headache with severe chills with total lack of energy.   At approximately 3 am I woke up in a severe sweat. My bed clothing, hair and bedding was soaked, sweat was literally dripping off of my hair.  At 7 am, when I rolled over in bed I became extremely dizzy, the room was spinning.  I layed still the dizziness eventually went away,  when I rolled over the dizziness came back for approximately 30 seconds. When I sat up,  it happened again.   I was able to somewhat function yesterday,  moving slowly.  Today it is much worse.  I am constantly dizzy and can not do daily functions.  I had vertigo 3 years ago and it is like that.
Sore arm; Tiredness; Inappropriate schedule of vaccine administered; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), FATIGUE (Tiredness) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002F21A and 033C21A) for COVID-19 vaccination.     no medical history was reported.  Concurrent medical conditions included Angina pectoris, Blood pressure and Cholesterol. Concomitant products included ISOSORBIDE for Angina pectoris, LOSARTAN and HYDROCHLOROTHIAZIDE for Blood pressure, SIMVASTATIN for Cholesterol, CALCIUM CARBONATE, VITAMIN D NOS (CALCIUM + VIT D) and COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for an unknown indication.   On 17-May-2021 at 9:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Aug-2021 at 3:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Aug-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). On 15-Aug-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and FATIGUE (Tiredness). On 14-Aug-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) had resolved. On 17-Aug-2021, PAIN IN EXTREMITY (Sore arm) and FATIGUE (Tiredness) had resolved.            No treatment medications were reported.   This case was linked to MOD-2021-286661 (Patient Link).
Patient contracted COVID after being fully vaccinated Runny nose, cough, fatigue, congestion, chills, Body aches, headache.
dizziness; aches; fever; sniffles; pain at injection site; This is a spontaneous report from a contactable health care professional (patient). A 72-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number requested) via an unspecified route of administration on 13Jan2021 at 07:00 PM on the left arm at a single dose for COVID-19 immunization.  Medical history included hypothyroidism and allergies to eggs both from an unknown date and unknown if ongoing.  Concomitant medication included levothyroxine sodium (SYNTHROID). The patient did not have COVID-19 prior to vaccination. It was reported that on 14Jan2021 at 07:00 AM, 12 hours after the vaccine, the patient experienced dizziness, aches, fever, sniffles and pain at injection site.  The outcome of the events was recovered on an unspecified date in Jan2021. The patient did not receive any treatment for the events. The patient has not been tested for COVID-19 post vaccination.   Information on the lot/batch number has been requested.
9.5 x 7 cm induration, erythema at injection site R arm N/V/D. Tmax 101 degrees.
Immediately following injection, swelling occurred at injection site.  Patient was given ice pack and observed for 30 minutes.  Redness was not noted and swelling subsided after ice pack applied.
seeing stars; felt unwell; This non-serious case was reported by a physician and described the occurrence of visual flashes in a 6-decade-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced visual flashes (Verbatim: seeing stars) and feeling unwell (Verbatim: felt unwell). The outcome of the visual flashes was not reported and the outcome of the feeling unwell was resolved.   The reporter considered the visual flashes to be related to Shingrix. It was unknown if the reporter considered the feeling unwell to be related to Shingrix.     The company considered the visual flashes to be related to Shingrix. It was unknown if the company considered the feeling unwell to be related to Shingrix.   Additional Information: GSK Receipt date: 28-APR-2023 This case was submitted by GlaxoSmithKline employee (doctor) via the online direct entry reporting system. The reporter reported that the patient received a dose of Shingles vaccine and during and IME program on shingles and the moderator asked the audience how many received Shingles vaccine, and if anyone experienced adverse event, then stated that one person shouted out and he felt unwell for a few days and was seeing stars. The room contained over 100 people and the reporter was not able to identify the audience member. The reporter did not consent to follow up.
After inoculation. Patient passed out and fell backward. She hit her head on the floor. She received concussion.
Fever, myalgia, induration, headaches, malaise x2 days. Arm pain, induration, myalgia for 2 wks.
Patient woke up at 1ma the morning after her second dose of the Pfizer Bio N Tech vaccine. She was having "convulsions" of arms and legs but remained fully conscious. this lasted 30 min. she was able to speak during this time. It stopped. She returned to sleep. no loss of bowel or bladder control. She went back to sleep once it stopped. she woke up later in the AM. she had mild headache. she called Health Clinic and advised what happened earlier. she was advised to go to ER for evaluation. She did She has made full Recovery.
Td was administered on 10/14/03. After 24 hours the pt developed swelling from the top of the arm (deltoid area) to the area above the elbow. (Left arm induration 10cm x 8cm). The area was also erythematous.
Seizures 1 hour after vaccination Allergic reaction (tingling/itchy/swollen mouth, lips, tongue and throat and shortness of breath, hives)
forty three children were administered varicella virus vaccine from a shipment that was stored out of the refrigerator for 5 days; This spontaneous report has been received from unspecified reporter via company representative concerning a children of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not provided.  On an unknown date, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) (dose, frequency, route, lot number and expiration date were not provided) for prophylaxis. The reporter stated that the patient was vaccinated from a shipment that was stored out of the refrigerator for 5 days.  This is one of 45 case reported by the same reporter.
Developed rectal bleeding (red blood) about 18 hours after immunization. Now on 9/5/06, she still have some bleeding.
Patient reports chills, fatigue, body aches, and lymphadenopathy in right axilla.
Mother reported after 24 hrs she developed a fever of 101 and her arm was very swollen. Fever lasted for 4 days. Treatment at home, mother then said after nurse asked her again if she ever remembered a rxn and she thought she had a rxn in 2010 to something, and it was probably the DTaP.
Cluster of vesicular leisons with red bases in various statges on left upper abdomen. (#ig 6) 1 vesicle on Right shoulder 1 papule on left thigh
12/17 6:30 pm- started to have general malaise to the point I couldn't cut carrots in the kitchen, then 645pm- 9pm general chills, sweating, muscle ache and pains, severe headache (unresponsive to ibuprofen 600 mg x1 and APAP 1 g x1), 10pm fever of 100.4 F, at 11 pm, symptoms started to decrease, by 12 pm 12/18, all symptoms suddenly stopped  12/19 woke up with sore throat, and overall consistent general malaise  12/20 sore throat continues, mild headaches  12/21 sore throat continues and muscle pain/chills returned   note all other activities remained the same, and no new introduction of OTC/prescription medications, or change in daily activities
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. Information regarding medical history, concurrent conditions and concomitant medications was not provided. During 2013, the patient was inoculated with ZOSTAVAX at a hospital for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain condition of herpes zoster.  During 2016, she was treated at the same hospital for a blistering vesicular outbreak and decreased immune symptoms which was then diagnosed as herpes zoster, or shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcomes of the events were unknown at the time of reporting. Causality assessment was related. Additional information has been requested.
Mom described the reaction as unconsolable screaming x 2 hrs; no fever; Slept well p/this & fine the next AM;
As previously recorded, employee reported chest pains, intermittent and recurrent throughout the night of 1/21.
Saw flashing lights withing 5 minutes of receiving vaccine.  Visual disturbances lasted about 10-15 minutes.  Pt also experienced chills/shakes approximately 15 minutes post vaccination.
TUES:  Approximately 8 hours after the Covid shot, patient developed violent shaking, extreme pain throughout her body and became disoriented & confused.  She did not have a fever.  At 9:30 pm the home health nurse said to give Pt Tylenol which we didn't have so she said give her 2 Advil.             At 11:30 pm Patient fell asleep.   WEDS: Patient awoke 1:30 am.  Her pain was still very bad and she was confused.  She was given 2 advil.  At 3:30 am she fell asleep.  At 8:30 am she awoke and couldn't recall anything that had happened. Her mental state appeared to be better, however, the situation quickly deteriorated.  She became agitated, began hallucinating and repeating what said to her, and  started calling objects by the wrong names. The overall body pain seemed to have subsided.  At 4:00 pm the home health nurse came by to take her vitals, which were all normal.  At 7:00 pm Dr. prescribed an anxiety medication.  THURS: Patient awoke at 12:30 am.  She was confused, combative and unable to follow instructions.  The paramedics were called and she was taken to hospital.  She remained in the hospital through Sunday and was transferred to a Board & Care facility because she currently needs 24 hour care. MON: Mental state appears to be improving however, she has tactile sensitivity (painful to the touch) throughout her body.
Very tired feeling; Chills; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 21-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 28Apr2021 at 18:15 (at the age of 21-years-old) as a single dose for COVID-19 immunisation. Medical history included schizophrenia. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included prazosin hydrochloride (PRAZOSIN), trazodone (MANUFACTURER UNKNOWN), olanzapine (ZYPREXA), sertraline (MANUFACTURER UNKNOWN) and benzatropine mesilate (COGENTIN); all for unknown indication from an unknown date and unknown if ongoing. On 28Apr2021 at 19:15, the patient experienced very tired feeling, chills and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event very tired feeling, chills and nausea was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Pain, swelling, redness to distal L upper extremity & hand sweating. Hyperaesthesia, s/p vaccine x 2 in WE. Concerned about reflex sympathetic dystrophy. Referred to Neurologist. Possible surgery needed.
patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication reported.   No Treatment Medication reported.
On the afternoon of July 15, 2022. It felt like a head cold with itchy eyes, like an allergy. I took a rapid test and it came back positive. I called my doctor to discuss PAXLOVID. The after hours doctor prescribed it and I began taking it the next morning, Saturday. I felt better Saturday evening. Completed the 5 days treatment. I felt better as the treatment went on. I did have a hacking cough throughout the infection and mild headaches on and off. I continued to be very tired as well. I felt better by Thursday but felt much worse on Friday. I assumed I had the PAXLOVID rebound. I did not test negative until after day 14. As of today, August 25, 2022, I still have an occasional cough and that is the only lingering symptom.
pt states that she had vaccine on 1/9 later that night she had splochy rash on chest that resolved on own over night sunday 1/10 she felt feverish, bodyaches and chills with nausea and vomiting continued all day and over night was taking tylenol with mild relief of fever and body aches  syptoms have somewhat resolved
2 days after 2nd moderna vaccine started having significant hives - worst over R arm (location of shot) but also over L arm, torso, both thighs. Has now got them recurrently every day for 3 weeks - some days worse than others. responding well to ant-histamines. no GI or pulm symptoms. Is starting to slowly improve but still persistant
itching sensation on his nose; This is a spontaneous report from a contactable consumer. This consumer (patient's mother) reported for (reporter's son) that:   A 16-years-old male patient received first dose of bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date (age at vaccination 16 years) as dose 1, single for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first dose of the Pfizer COVID-19 vaccine on Monday and the next day he woke up with an itching sensation on his nose, when he scratched it caused a lot of bleeding on his nose, after cleaning up the patient and holding his nose with a towel the bleeding stopped 5 minutes later. They were worried because something like that never happened before. Since the patient had an appointment to receive the second dose in two weeks caller wants to know if they should discuss this with the vaccination provider. No reports of nose bleeding after receiving the vaccination, referred to his physician for treatment recommendation. This does not mean the medication could not cause this but it was not something reported in the information of the product. The outcome if event was reported as unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Flu like symptoms/body aches/fever; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms/body aches/fever) and VACCINATION SITE PAIN (Sore arm) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms/body aches/fever) and VACCINATION SITE PAIN (Sore arm). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms/body aches/fever) and VACCINATION SITE PAIN (Sore arm) had not resolved.            No concomitant drug were reported. No treatment information was reported. Action taken with mRNA-1273 in response to the events was not applicable.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, vaccination site pain and Influenza like illness, a causal relationship cannot be excluded.
Moderna Covid-19 vaccine drawn up into individual syringes at about 745pm - 8pm on 3/24/2021, vaccine was administered to patient at 1:30pm  3/25/21, outside the recommended 6 hours after vial puncture. Vaccine remained in the refrigerator from the time drawn up to administration. Vaccine was inspected there was no particulate matter or discoloration prior to administration.
severe pain in arm / still experiencing a sore arm / arm functions but it is still sore and it hurts when tries to; Fever (102); This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (severe pain in arm / still experiencing a sore arm / arm functions but it is still sore and it hurts when tries to) and PYREXIA (Fever (102)) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 009C21A and 018B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Apr-2021, the patient experienced PAIN IN EXTREMITY (severe pain in arm / still experiencing a sore arm / arm functions but it is still sore and it hurts when tries to). 27-Apr-2021, the patient experienced PYREXIA (Fever (102)). At the time of the report, PAIN IN EXTREMITY (severe pain in arm / still experiencing a sore arm / arm functions but it is still sore and it hurts when tries to) and PYREXIA (Fever (102)) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant Medications were provided.  No Treatment information were provided   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Follow up information included additional event included fever and outcome of the earlier reported event (pain in arm).
Patient experienced severe pain in left shoulder in which vaccination was administered. The pain caused immobility in left shoulder and difficulty sleeping due to pain. The pain was described as extremely sore when immobile and sharp pain when mobile. Any type of movement caused pain to the shoulder area during a two week period in which the pain was severe. The patient is still feeling soreness in the left shoulder although the pain is mild. Furthermore, the patient exhibited flu symptoms such as chills, high fever (103), severe body aches, and fatigue. These symptoms were severe for 4 days and lasted in some manner for 8 days.
Left Hemispheric Stroke with Right Hemiplegia and loss of speech.   5 days after 2nd dose of Moderna.
Patient received the Pfizer vaccine on 3/24/21 and 4/14/21 so was fully vaccinated when they tested positive for COVID-19 on 9/14/21.
Pt exp a burning sensation & discomfort (pain) @ inject site immediately p/receiving Influenza vax; sx subsided 15-25 seconds p/the inject, & no other problems were noted in pt;
Red dot at injection site the following morning increased in redness w/2 large circular areas at injection sites. Swelling in left thigh and low grade fever of around 100 deg. Antibiotic prescription by physician. Pronounced generalized left thigh swelling, warmth - tenderness.
Mother called to say patient's thighs were red and swollen. He was also vomiting anything he drank. Recommended that she put cool compresses on his thighs and take him to the health clinic on 14.7 to be seen by a physician.